Total Funding
68
16
Total FundingPost-IPO Equity raised
Growth Score
-16 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
215189
Kite Pharma is a biotechnology company that designs and develops immune-based therapies to treat cancer indications.
Acquired by 
Gilead Sciences
- Vadim Yuzhakov: Director of Process EngineeringPast Role: Ximedica, Director of Engineering
Joseph Wong: Director, Global Commercial Analytics
Gilead Sciences
About the Company
Kite Pharma is a privately held development stage biotechnology company engaged in the design and development of pioneering immune-based targeted therapies to treat different cancer indications. Kite has a portfolio of proprietary product candidates designed to stimulate the patient's own immune system to fight tumor cells. These potential
therapies could provide novel strategies for the treatment and management of a wide range of tumor types.
